PRKAR1A mutations in primary pigmented nodular adrenocortical disease

Pituitary

Volumn 9, Issue 3, 2006, Pages 211-219

  Cazabat, Laure ^a,b   Ragazzon, Bruno ^a,b   Groussin, Lionel ^a,b,c   Bertherat, Jérôme ^a,b,c,d  

^a INSERM   (France)

^b INSTITUT COCHIN   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

cAMP; Carney complex; Cushing's syndrome; Primary pigmented nodular adrenocortical disease; PRKAR1A

Indexed keywords

CORTICOTROPIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DEXAMETHASONE; HYDROCORTISONE; KETOCONAZOLE; MITOTANE; PHOSPHODIESTERASE;

ADRENAL CORTEX DISEASE; ADRENALECTOMY; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CARNEY COMPLEX; CHROMOSOME 17Q; CHROMOSOME 2Q; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CUSHING SYNDROME; DISEASE ASSOCIATION; ENZYME SUBUNIT; FAMILY HISTORY; GENE IDENTIFICATION; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION; GENOTYPE PHENOTYPE CORRELATION; GERM LINE; HETEROZYGOSITY; HUMAN; LINKAGE ANALYSIS; MICROSCOPY; MYXOMA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKIN PIGMENTATION; URINALYSIS;

ADRENAL CORTEX DISEASES; ANIMALS; CUSHING SYNDROME; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASE RIALPHA SUBUNIT; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENETIC PREDISPOSITION TO DISEASE; HORMONES; HUMANS; MULTIPLE ENDOCRINE NEOPLASIA; MUTATION; PIGMENTATION DISORDERS; SIGNAL TRANSDUCTION;

EID: 33751009673     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-006-0266-1     Document Type: Article

References (49)

1. Bertherat J, Gimenez-Roqueplo AP (2005) New insights in the genetics of adrenocortical tumors, pheochromocytomas and paragangliomas. Horm Metab Res 37(6):384-390
2. Carney JA, Gordon H, Carpenter PC, Shenoy BV, Go VL (1985) The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine (Baltimore) 64(4):270-283
3. Stratakis CA, Kirschner LS (1998) Clinical and genetic analysis of primary bilateral adrenal diseases (micro- and macronodular disease) leading to Cushing syndrome. Horm Metab Res 30(6-7):456-463
4. Groussin L, Cazabat L, Rene-Corail F, Jullian E, Bertherat J (2005) Adrenal pathophysiology: Lessons from the Carney complex. Horm Res 64(3):132-139
5. Lacroix A, Ndiaye N, Tremblay J, Hamet P (2001) Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome. Endocr Rev 22(1):75-110
6. Bertherat J, Contesse V, Louiset E et al (2005) In vivo and in vitro screening for illegitimate receptors in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome: identification of two cases of gonadotropin/gastric inhibitory polypeptide-dependent hypercortisolism. J Clin Endocrinol Metab 90(3):1302-1310
7. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM (1991) Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 325:1688-1695
8. Meador CK, Bowdoin B, Owen WC, Farmer TA (1967) Primary adrenocortical nodular dysplasia: A rare cause of Cushing's syndrome. J Clin Endocrinol Metab 27:1255-1263
9. Bricaire H, Luton JP, Ghozland M, Forest M (1970) La polymicroadénomatose de la cortico-surrénale dans le syndrome [Polymicroadenomatosis of the adrenal cortex in Cushing's syndrome. 15 cases]. Ann Med Interne (Paris) 121(10):755-777
10. de Gennes JL, Garnier H, Calmette, Malinsky M, Bertrand C (1970) Etude clinique, biologique et histologique d'un cas exemplaire de polymicroadenomatose cortico-surrenale [Clinical, biological and histological study of a typical case of polymicroadenomatosis of the adrenal cortex]. Ann Endocrinol (Paris) 31(5):1022-1038
11. Ruder HJ, Loriaux DL, Lipsett MB (1974) Severe osteopenia in young adults associated with Cushing's syndrome due to micronodular adrenal disease. J Clin Endocrinol Metab 39(6):1138-1147
12. Shenoy BV, Carpenter PC, Carney JA (1984) Bilateral primary pigmented nodular adrenocortical disease. Rare cause of the Cushing syndrome. Am J Surg Pathol 8(5):335-344
13. Carney JA, Young WF (1992) Primary pigmented nodular adrenocortical disease and its associated conditions. The Endocrinologist 2:6-21
14. Stratakis CA, Kirschner LS, Carney JA (2001) Clinical and molecular features of the Carney complex: Diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab 86(9):4041-4046
15. Carney JA, Hruska LS, Beauchamp GD, Gordon H (1986) Dominant inheritance of the complex of myxomas, spotty pigmentation, and endocrine overactivity. Mayo Clin Proc 61(3):165-172
16. Stratakis CA, Carney JA, Lin JP et al (1996) Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2. J Clin Invest 97(3):699-705
17. Casey M, Mah C, Merliss AD et al (1998) Identification of a novel genetic locus for familial cardiac myxomas and Carney complex. Circulation 98(23):2560-2566
18. Kirschner LS, Carney JA, Pack SD et al (2000) Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet 26(1):89-92
19. Casey M, Vaughan CJ, He J et al (2000) Mutations in the protein kinase A R1alpha regulatory subunit cause familial cardiac myxomas and Carney complex. J Clin Invest 106(5): R31-R38
20. Horvath A, Boikos S, Giatzakis C et al (2006) A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia. Nat Genet 38(7):794-800
21. Groussin L, Jullian E, Perlemoine K et al (2002) Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease. J Clin Endocrinol Metab 87(9):4324-4329
22. Gunther DF, Bourdeau I, Matyakhina L et al (2004) Cyclical Cushing syndrome presenting in infancy: An early form of primary pigmented nodular adrenocortical disease, or a new entity? J Clin Endocrinol Metab 89(7):3173-3182
23. Caticha O, Odell WD, Wilson DE et al (1993) Estradiol stimulates cortisol production by adrenal cells in estrogen-dependent primary adrenocortical nodular dysplasia. J Clin Endocrinol Metab 77(2):494-497
24. Pack SD, Kirschner LS, Pak E, Zhuang Z, Carney JA, Stratakis CA (2000) Genetic and histologic studies of somatomammotropic pituitary tumors in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas" (Carney complex) [In Process Citation]. J Clin Endocrinol Metab 85(10):3860-3865
25. Stratakis CA, Sarlis N, Kirschner LS et al (1999) Paradoxical response to dexamethasone in the diagnosis of primary pigmented nodular adrenocortical disease. Ann Intern Med 131(8): 585-591
26. Bourdeau I, Lacroix A, Schurch W, Caron P, Antakly T, Stratakis CA (2003) Primary pigmented nodular adrenocortical disease: Paradoxical responses of cortisol secretion to dexamethasone occur in vitro and are associated with increased expression of the glucocorticoid receptor. J Clin Endocrinol Metab 88(8): 3931-3937
27. Cazabat L, Groussin L, Rene-Corail F, Jullian E, Bertagna X, Bertherat J (2005) [Pigmented micronodular dysplasia of the adrenal glands and Carney complex]. Ann Endocrinol (Paris) 66(3):187-193
28. Courcoutsakis NA, Patronas NJ, Cassarino D et al (2004) Hypodense nodularity on computed tomography: Novel imaging and pathology of micronodular adrenocortical hyperplasia associated with myelolipomatous changes. J Clin Endocrinol Metab 89(8):3737-3738
29. Sarlis NJ, Chrousos GP, Doppman JL, Carney JA, Stratakis CA (1997) Primary pigmented nodular adrenocortical disease: Reevaluation of a patient with carney complex 27 years after unilateral adrenalectomy. J Clin Endocrinol Metab 82(4):1274-1278
30. Oelkers W, Bahr V, Hensen J, Pickartz H (1986) Primary adrenocortical micronodular adenomatosis causing Cushing's syndrome. Effects of ketoconazole on steroid production and in vitro performance of adrenal cells. Acta Endocrinol (Copenh) 113(3):370-377
31. Cignarelli M, Picca G, Campo M et al (2005) A six month mitotane course induced sustained correction of hypercortisolism in a young woman with PPNAD and Carney complex. J Endocrinol Invest 28(1):54-60
32. Bertherat J (2006) Carney complex (CNC). Orphanet J Rare Dis 1:21
33. Kirschner LS, Sandrini F, Monbo J, Lin JP, Carney JA, Stratakis CA (2000) Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the Carney complex. Hum Mol Genet 9(20):3037-3046
34. Veugelers M, Wilkes D, Burton K et al (2004) Comparative PRKAR1A genotype-phenotype analyses in humans with Carney complex and prkar1a haploinsufficient mice. Proc Natl Acad Sci U S A 101(39):14222-14227. Epub 2004 Sep. 15
35. Groussin L, Kirschner LS, Vincent-Dejean C et al (2002) Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: Augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD. Am J Hum Genet 71(6): 1433-1442
36. Groussin L, Horvath A, Jullian E et al (2006) A PRKAR1A mutation associated with primary pigmented nodular adrenocortical disease in 12 kindreds. J Clin Endocrinol Metab 91(5): 1943-1949
37. Bertherat J, Groussin L, Sandrini F et al (2003) Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity. Cancer Res 63(17):5308-5319
38. Bourdeau I, Matyakhina L, Stergiopoulos SG, Sandrini F, Boikos S, Stratakis CA (2006) 17q22-24 chromosomal losses and alterations of protein kinase A (PKA) subunits expression and activity in ACTH-independent macronodular adrenal hyperplasia (AIMAH). J Clin Endocrinol Metab
39. BosNis I, Stratakis CA (2004) Minireview: PRKAR1A: normal and abnormal functions. Endocrinology 145(12):5452-5458. Epub 2004 Aug. 26
40. Rosenberg D, Groussin L, Jullian E, Perlemoine K, Bertagna X, Bertherat J (2002) Role of the PKA-regulated transcription factor CREB in development and tumorigenesis of endocrine tissues. Ann NYAcad Sci 968:65-74
41. Tasken K, Aandahl EM (2004) Localized effects of cAMP mediated by distinct routes of protein kinase A. Physiol Rev 84(1):137-167
42. Tsilou ET, Chan CC, Sandrini F et al (2004) Eyelid myxoma in Carney complex without PRKAR1A allelic loss. Am J Med Genet 130A(4):395-397
43. Amieux PS, Howe DG, Knickerbocker H et al (2002) Increased basal cAMP-dependent protein kinase activity inhibits the formation of mesoderm-derived structures in the developing mouse embryo. J Biol Chem 277(30):27294-27304
44. Kirschner LS, Kusewitt DF, Matyakhina L et al (2005) A mouse model for the Carney complex tumor syndrome develops neoplasia in cyclic AMP-responsive tissues. Cancer Res 65(11):4506-4514
45. Griffin KJ, Kirschner LS, Matyakhina L et al (2004) Down-regulation of regulatory subunit type 1A of protein kinase A leads to endocrine and other tumors. Cancer Res 64(24):8811-8815
46. Griffin KJ, Kirschner LS, Matyakhina L et al (2004) A transgenic mouse bearing an antisense construct of regulatory subunit type 1A of protein kinase A develops endocrine and other tumours: Comparison with Carney complex and other PRKAR1A induced lesions. J Med Genet 41(12):923-931
47. Robinson-White A, Meoli E, Stergiopoulos S et al (2006) PRKAR1A Mutations and protein kinase A interactions with other signaling pathways in the adrenal cortex. J Clin Endocrinol Metab 91(6):2380-2388
48. Robinson-White A, Hundley TR, Shiferaw M, Bertherat J, Sandrini F, Stratakis CA (2003) Protein kinase-A activity in PRKAR1A-mutant cells, and regulation of mitogen-activated protein kinases ERK1/2. Hum Mol Genet 12(13): 1475-1484
49. Horvath A, Mathyakina L, Vong Q et al (2006) Serial analysis of gene expression in adrenocortical hyperplasia caused by a germline PRKAR1A mutation. J Clin Endocrinol Metab 91(2): 584-596